异丙酚靶向BPIFB1/TLR4轴调控小胶质细胞极化以改善脑缺血/再灌注损伤
DOI:
作者:
作者单位:

河南省中医院(河南中医药大学第二附属医院)

作者简介:

通讯作者:

中图分类号:

基金项目:

河南省中医药科学研究专项课题(2025LHZX2140)


Propofol Targets the BPIFB1/TLR4 Axis to Regulate Microglial Polarization and Ameliorate Cerebral Ischemia/Reperfusion Injury
Author:
Affiliation:

Henan Provincial Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨异丙酚(Propofol)是否通过调控BPI折叠内含蛋白B1(BPIFB1)/Toll样受体4(TLR4)通路影响小胶质细胞极化,进而减轻脑缺血/再灌注(I/R)损伤。 方法 建立小鼠大脑中动脉阻塞(MCAO)模型,分为假手术组、MCAO模型组和MCAO+异丙酚组。采用TTC染色、神经功能评分、免疫荧光、qPCR和Western blot评估脑损伤、小胶质细胞极化及BPIFB1/TLR4表达。BV2小胶质细胞构建氧糖剥夺(OGD)模型,分为对照组、OGD模型组和OGD+异丙酚组,采用免疫荧光、qPCR和Western blot检测极化状态与BPIFB1/TLR4表达;并通过分子对接与siRNA敲低技术分析异丙酚与BPIFB1的相互作用及BPIFB1的功能。 结果 体内实验表明,异丙酚能显著改善MCAO小鼠神经功能、减轻脑梗死体积及水肿,抑制脑组织小胶质细胞M1极化并促进M2极化,同时上调BPIFB1、抑制TLR4表达(P < 0.05)。体外实验进一步表明,异丙酚预处理可抑制OGD诱导的BV2细胞M1极化、促进M2极化,并上调BPIFB1、下调TLR4蛋白水平(P < 0.05)。分子对接分析表明,异丙酚与BPIFB1蛋白具有潜在的结合能力;敲低BPIFB1可逆转异丙酚对M2极化的促进、对TLR4的抑制及其细胞保护作用(P < 0.05)。结论 异丙酚通过BPIFB/TLR4信号通路调控促进小胶质细胞向M2抗炎表型极化,从而在脑缺血再灌注损伤中发挥神经保护作用。

    Abstract:

    Objective To investigate whether propofol alleviates cerebral ischemia/reperfusion (I/R) injury by modulating the BPI fold-containing family B member 1 (BPIFB1)/Toll-like receptor 4 (TLR4) pathway to influence microglial polarization. Methods A middle cerebral artery occlusion (MCAO) model was established in mice and divided into sham operation group, MCAO model group, and MCAO + propofol group. TTC staining, neurological function scoring, immunofluorescence, qPCR, and Western blot were used to assess cerebral injury, microglial polarization, and BPIFB1/TLR4 expression. An oxygen-glucose deprivation (OGD) model was constructed in BV2 microglial cells and divided into control group, OGD model group, and OGD + propofol group. Immunofluorescence, qPCR, and Western blot were employed to examine the polarization status and BPIFB1/TLR4 expression. Additionally, molecular docking and siRNA knockdown techniques were applied to analyze the interaction between propofol and BPIFB1 as well as the function of BPIFB1. Results In vivo, propofol significantly improved neurological function, reduced cerebral infarct volume and edema, inhibited M1 polarization while promoting M2 polarization of microglia, and upregulated BPIFB1 while downregulating TLR4 expression (P < 0.05). In vitro, propofol pretreatment inhibited OGD-induced M1 polarization, promoted M2 polarization, and correspondingly altered BPIFB1 and TLR4 protein levels (P < 0.05). Molecular docking suggested a potential binding affinity between propofol and BPIFB1. Knockdown of BPIFB1 reversed propofol's effects on promoting M2 polarization, inhibiting TLR4, and its cytoprotective action (P < 0.05). Conclusion Propofol protects against cerebral I/R injury by modulating the BPIFB1/TLR4 pathway to shift microglial polarization to the protective M2 phenotype.

    参考文献
    相似文献
    引证文献
引用本文
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-02-05
  • 最后修改日期:2026-04-30
  • 录用日期:2026-11-03
  • 在线发布日期:
  • 出版日期: